Randomized phase II study of sorafenib and hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma.
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2016
At a glance
- Drugs Sorafenib (Primary) ; Cisplatin
- Indications Liver cancer
- Focus Therapeutic Use
- 01 Nov 2016 Results (n=108) published in the Annals of Oncology.
- 29 Jul 2015 Status changed from recruiting to completed, as reported by University Hospital Medical Information Network- Japan record (UMIN000005703)
- 03 Jun 2011 New trial record